Stock Events

Stock Events

Nova Eye Medical Limited 

$0
6
+$0+0% Monday 19:13

Statistics

Day High
0
Day Low
0
52W High
0.1
52W Low
0
Volume
1,000
Avg. Volume
0
Mkt Cap
539,877.4
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 20
$0.1
Dec 2
$0.02
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

24FebExpected
Q2 2023
Q3 2023
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.03
-0.02
-0.01
-0
Expected EPS
-0.004725432707288747
Actual EPS
-0.011152021189201444

Financials

-30.81%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
37.99MRevenue
-11.7MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ELXMF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its subsidiary Janssen Pharmaceuticals, competes in various healthcare sectors including eye health, making it a competitor in the ophthalmic market.
Novartis
NVS
Mkt Cap237.61B
Novartis AG, with its division Alcon, specializes in eye care products ranging from surgical devices to contact lenses, directly competing in Nova Eye Medical's market.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, after acquiring Allergan, has a strong presence in the eye care market, especially in treatments for eye conditions, competing with Nova Eye Medical's offerings.
Bausch Health Companies
BHC
Mkt Cap2.62B
Bausch Health Companies, through its subsidiary Bausch + Lomb, provides a wide range of eye health products, competing across several of Nova Eye Medical's key areas.
Cooper Companies
COO
Mkt Cap13.9B
The Cooper Companies operate through CooperVision and CooperSurgical, with CooperVision being a significant player in the contact lens market, indirectly competing with Nova Eye Medical.
Staar Surgical
STAA
Mkt Cap1.28B
STAAR Surgical Company specializes in the development, manufacture, and marketing of implantable lenses for the eye and delivery systems, competing in the surgical eye care segment.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences, a provider of surgical instruments and devices, competes in the broader medical technology market, including some ophthalmic surgical products.

About

Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. It also engaged in the commercialisation of the subthreshold nano-pulse ophthalmic laser; 2RT, a proprietary laser technology to treat patients in early and intermediate age-related macular degeneration for the treatment of retinal disease. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in patients glaucoma; iTrack Advance; and Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
Show more...
CEO
Mr. Victor Previn
Country
AU
ISIN
AU0000094252

Listings

OTC Link
US
ELXMF
AU
AU
EYE.AU

0 Comments

Share your thoughts

FAQ

What is Nova Eye Medical Limited stock price today?▼
The current price of ELXMF is $0 USD — it has increased by +0% in the past 24 hours. Watch Nova Eye Medical Limited stock price performance more closely on the chart.
What is Nova Eye Medical Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nova Eye Medical Limited stocks are traded under the ticker ELXMF.
What is Nova Eye Medical Limited market cap?▼
Today Nova Eye Medical Limited has the market capitalization of 539,877.4
When is the next Nova Eye Medical Limited earnings date?▼
Nova Eye Medical Limited is going to release the next earnings report on August 26, 2026.
What were Nova Eye Medical Limited earnings last quarter?▼
ELXMF earnings for the last quarter are -0.01 USD per share, whereas the estimation was -0 USD resulting in a -136% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nova Eye Medical Limited revenue for the last year?▼
Nova Eye Medical Limited revenue for the last year amounts to 37.99M USD.
What is Nova Eye Medical Limited net income for the last year?▼
ELXMF net income for the last year is -11.7M USD.
Does Nova Eye Medical Limited pay dividends?▼
Yes, ELXMF dividends are paid en. The last dividend per share was 0.1 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Nova Eye Medical Limited located?▼
Nova Eye Medical Limited operates in the Health Care sector.
When did Nova Eye Medical Limited complete a stock split?▼
Nova Eye Medical Limited has not had any recent stock splits.
Where is Nova Eye Medical Limited headquartered?▼
Nova Eye Medical Limited is headquartered in Kent Town, AU.